The global cancer immunotherapy market is expected to grow at a CAGR of 13.8% from 2018 to 2024 to reach USD 152.83 billion by 2024. Cancer immunotherapy is a treatment that uses body’s own immune system to help fight cancer. Cancer cells have the ability to invade the immune system through various mechanisms. Immunotherapy focuses on these mechanisms and develops other mechanism to restore the immune system and its ability to destroy the cancer cells. Rising incidence of cancer globally, rising adoption of cancer immunotherapies over other conventional cancer treatments owing to the increased survival rate and less side effects with immunotherapy drugs, increasing number of ongoing clinical trials with the help of rising investments by major players in the market, and development of bioinformatics tools that are enhancing the drug development process for cancer immunotherapy market are the major factors driving the growth of overall cancer immunotherapy market.
https://www.meticulousresearch.com/product/cancer-immunotherapy-market/
No comments:
Post a Comment